Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001607700-16-000002
Filing Date
2016-02-16
Accepted
2016-02-16 12:09:32
Documents
1
Effectiveness Date
2016-02-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8796
  Complete submission text file 0001607700-16-000002.txt   9930
Mailing Address 219 TERRY AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 219 TERRY AVENUE NORTH, SUITE 300 SEATTLE WA 98109 206-378-0400
KPI Therapeutics, Inc. (Filer) CIK: 0001607700 (see all company filings)

IRS No.: 300786656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-257506 | Film No.: 161425229